Ireland-USA Bilateral Trade Analysis 2023

Complete trade statistics: $84.99B total volume โ€ขIreland surplus: $40.26B

Ireland โ†’ USA

$62.63B

Exports (2023)

USA โ†’ Ireland

$22.36B

Imports (2023)

Trade Balance

$40.26B

Surplus for Ireland

Total Trade

$84.99B

Combined Volume

Trade Flow Visualization

Direct trade relationship between Ireland and USA. Green line shows exports from Ireland, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Ireland-USA commercial relationship and competitive positioning in global markets.

Ireland โ†’ USA Exports

$62.63B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
14.5% top product
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$9.11B
14.5% of exports
2Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts
$7.83B
12.5% of exports
3Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$5.13B
8.2% of exports
4Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale
$5.11B
8.2% of exports
5Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
$4.23B
6.8% of exports
6Vaccines: for human medicine
$3.98B
6.4% of exports
7Odoriferous substances and mixtures: of a kind used in the food or drink industries
$3.53B
5.6% of exports
8Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
$2.83B
4.5% of exports
9Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN)
$2.19B
3.5% of exports
10Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934
$1.89B
3.0% of exports

๐ŸŽฏ Strategic Export Focus

Ireland's export portfolio to USA demonstrates strong diversification across multiple sectors, with medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.

USA โ†’ Ireland Imports

$22.36B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
32.9% concentration
1Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg
$7.36B
32.9% of imports
2Oils: petroleum oils and oils obtained from bituminous minerals, crude
$1.28B
5.7% of imports
3Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$805.76M
3.6% of imports
4Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale
$769.60M
3.4% of imports
5Toxins, cultures of micro-organisms (excluding yeasts) and similar products
$760.03M
3.4% of imports
6Machines and apparatus of a kind used solely or principally for the manufacture of semiconductor devices or of electronic integrated circuits
$674.84M
3.0% of imports
7Electronic integrated circuits: processors and controllers, whether or not combined with memories, converters, logic circuits, amplifiers, clock and timing circuits, or other circuits
$668.63M
3.0% of imports
8Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$639.48M
2.9% of imports
9Medical, surgical instruments and appliances: catheters, cannulae and the like
$304.46M
1.4% of imports
10Vaccines: for human medicine
$295.17M
1.3% of imports

๐Ÿ“ฆ Import Strategy Analysis

Ireland's import pattern from USA reveals significant dependencyin aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

๐Ÿ†

Market Leadership

Ireland demonstrates competitive strength in exportingmedicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale to USA, leveraging comparative advantages.

Export Leader in 20+ Categories
๐Ÿ”„

Trade Complementarity

The bilateral relationship showsmoderatecomplementarity, with each country specializing in different sectors.

Specialized Exchange
๐Ÿ“ˆ

Growth Potential

The $84.99B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Major Partnership

Executive Summary: Ireland-USA Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $84.99 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: Ireland maintains a surplus of $40.26 billion
  • Export Focus: Ireland's primary exports include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts, blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
  • Import Dependencies: Key imports from USA include aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg, oils: petroleum oils and oils obtained from bituminous minerals, crude, medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthImbalanced

๐Ÿ“ˆ Market Position: This bilateral trade relationship represents one of the world's largest trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $84.99B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Ireland leveraging its comparative advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Ireland's specialization in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail salecomplements USA's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $84.99B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyHigh
๐Ÿ”ฎ

Trade Relationship Outlook

The $84.99B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

๐Ÿ’ฐ

Trade Volume Impact

The $84.99 billion bilateral trade volume represents a major economic driverfor both economies.

Economic Significance: Very High
๐Ÿญ

Industrial Integration

Trade flows in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale and aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
โš–๏ธ

Trade Balance Effects

Ireland's trade surplus of $40.26 billion strengthens its overall economic position in this bilateral relationship.

Balance Impact: Export Advantage

Strategic Future Outlook

๐Ÿš€Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts present expansion opportunities.
Market Diversification
Beyond current focus on aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg, new product categories offer potential for trade expansion.

โš ๏ธRisk Factors

Supply Chain Vulnerabilities
High trade imbalance may create supply chain risks
Market Competition
Global competition in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale may affect future market positioning.

๐ŸŽฏStrategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Ireland and USA represents a total trade volume of $84.99 billion in 2023. This partnership demonstrates a favorable trade balance for Ireland, with exports exceeding importsby $40.26 billion.

Export Strengths

Ireland's exports to USA total $62.63 billion, with competitive advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, representing $9.11B or14.5% of bilateral exports.

Import Dependencies

Imports from USA amount to $22.36 billion, highlighting economic interdependence in aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg, with Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg comprising32.9% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates Ireland's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Ireland and USA in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) โ€ข Last Updated: January 2025 โ€ข Coverage: 1995-2023